4/17/2023 Beiersdorf Celebrating 25 Years of Q10 Innovation Power Coenzyme Q10 ushered in modern active ingredient cosmetics in the mass market 25 years ago and is still one of the most important active ingredients in the anti-aging segment.
1/16/2023 NIVEA develops unique cosmetic sunscreen NIVEA has tailored a unique cosmetic sun protection product, specially made for a girl named Charlotte with a rare light disease called EPP.
12/16/2022 Beiersdorf acquires S-Biomedic Beiersdorf AG announced today that it has acquired a majority stake in S-Biomedic NV, Belgium, a leading life-science company.
5/19/2022 International Who’s Who of Q10 Research Beiersdorf hosted the who’s who of international Q10 research at the tenth conference of the International Coenzyme Q10 Association (ICQA) held at its research center in Hamburg.
4/7/2022 An Industry Pioneer Beiersdorf Launches the World’s First Cosmetics Product with Recycled CO2.
2/3/2022 New Innovation Center in the US Skin care company Beiersdorf is opening a new chapter in the North American market with two inaugurals.
8/18/2021 Beiersdorf Enters Market for Post-Acne Marks Beiersdorf dermocosmetics brand Eucerin launches two new products worldwide for acne-prone skin: Eucerin DERMOPURE TRIPLE EFFECT SERUM with Thiamidol and the DERMOPURE PROTECTIVE FLUID SPF 30.
8/6/2021 Beiersdorf’s Berlin plant to be climate-neutral from 2022 onwards Another step towards climate protection: Beiersdorf will switch to biogas at its Berlin plant.
5/4/2021 Cell phone screens do not damage skin Beiersdorf study clears up misconceptions about blue light
11/19/2020 Beiersdorf continues to focus on innovation Beiersdorf invests in the future and constructs a state-of-the-art technology center in Hamburg.
5/12/2020 Evonik and Beiersdorf Engaging in Joint Research Its aim is to develop sustainable raw materials for care products.
1/8/2020 Beiersdorf and Insilico Medicine Employ AI Technology Beiersdorf uses artificial intelligence to accelerate the discovery of novel and safe active ingredients.